Clinical Trial Update: A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial assessed the combination of talazoparib and temozolomide in prostate cancer, including castration-resistant and metastatic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Talzenna (talazoparib)
• Temodar (Temozolomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer, Prostate Adenocarcinoma | Phase 1, Phase 2 | Status: COMPLETED